Global AI-based Antibody Development Platform Market Research Report 2024

Publication ID:

PB506243593

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
The global AI-based Antibody Development Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for AI-based Antibody Development Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Antibody Development Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AI-based Antibody Development Platform in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AI-based Antibody Development Platform include Kyinno Biotechnolog, XtalPi Inc, DenovAI Biotech, immunitoAI Private Limited, EVQLV, Creative Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-based Antibody Development Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Antibody Development Platform.
The AI-based Antibody Development Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-based Antibody Development Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-based Antibody Development Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kyinno Biotechnolog
XtalPi Inc
DenovAI Biotech
immunitoAI Private Limited
EVQLV
Creative Biolabs
Segment by Type
Antibody Generation and Screening
Discovery and Target Recognition
Engineering and Optimization
Other
Segment by Application
Pharmaceutical
Biotechnology
Academic Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-based Antibody Development Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Antibody Development Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody Generation and Screening
1.2.3 Discovery and Target Recognition
1.2.4 Engineering and Optimization
1.2.5 Other
1.3 Market by Application
1.3.1 Global AI-based Antibody Development Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-based Antibody Development Platform Market Perspective (2019-2030)
2.2 Global AI-based Antibody Development Platform Growth Trends by Region
2.2.1 Global AI-based Antibody Development Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-based Antibody Development Platform Historic Market Size by Region (2019-2024)
2.2.3 AI-based Antibody Development Platform Forecasted Market Size by Region (2025-2030)
2.3 AI-based Antibody Development Platform Market Dynamics
2.3.1 AI-based Antibody Development Platform Industry Trends
2.3.2 AI-based Antibody Development Platform Market Drivers
2.3.3 AI-based Antibody Development Platform Market Challenges
2.3.4 AI-based Antibody Development Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-based Antibody Development Platform Players by Revenue
3.1.1 Global Top AI-based Antibody Development Platform Players by Revenue (2019-2024)
3.1.2 Global AI-based Antibody Development Platform Revenue Market Share by Players (2019-2024)
3.2 Global AI-based Antibody Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-based Antibody Development Platform Revenue
3.4 Global AI-based Antibody Development Platform Market Concentration Ratio
3.4.1 Global AI-based Antibody Development Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Antibody Development Platform Revenue in 2023
3.5 Global Key Players of AI-based Antibody Development Platform Head office and Area Served
3.6 Global Key Players of AI-based Antibody Development Platform, Product and Application
3.7 Global Key Players of AI-based Antibody Development Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-based Antibody Development Platform Breakdown Data by Type
4.1 Global AI-based Antibody Development Platform Historic Market Size by Type (2019-2024)
4.2 Global AI-based Antibody Development Platform Forecasted Market Size by Type (2025-2030)
5 AI-based Antibody Development Platform Breakdown Data by Application
5.1 Global AI-based Antibody Development Platform Historic Market Size by Application (2019-2024)
5.2 Global AI-based Antibody Development Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-based Antibody Development Platform Market Size (2019-2030)
6.2 North America AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-based Antibody Development Platform Market Size by Country (2019-2024)
6.4 North America AI-based Antibody Development Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-based Antibody Development Platform Market Size (2019-2030)
7.2 Europe AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-based Antibody Development Platform Market Size by Country (2019-2024)
7.4 Europe AI-based Antibody Development Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-based Antibody Development Platform Market Size (2019-2030)
8.2 Asia-Pacific AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-based Antibody Development Platform Market Size (2019-2030)
9.2 Latin America AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-based Antibody Development Platform Market Size by Country (2019-2024)
9.4 Latin America AI-based Antibody Development Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-based Antibody Development Platform Market Size (2019-2030)
10.2 Middle East & Africa AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kyinno Biotechnolog
11.1.1 Kyinno Biotechnolog Company Details
11.1.2 Kyinno Biotechnolog Business Overview
11.1.3 Kyinno Biotechnolog AI-based Antibody Development Platform Introduction
11.1.4 Kyinno Biotechnolog Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.1.5 Kyinno Biotechnolog Recent Development
11.2 XtalPi Inc
11.2.1 XtalPi Inc Company Details
11.2.2 XtalPi Inc Business Overview
11.2.3 XtalPi Inc AI-based Antibody Development Platform Introduction
11.2.4 XtalPi Inc Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.2.5 XtalPi Inc Recent Development
11.3 DenovAI Biotech
11.3.1 DenovAI Biotech Company Details
11.3.2 DenovAI Biotech Business Overview
11.3.3 DenovAI Biotech AI-based Antibody Development Platform Introduction
11.3.4 DenovAI Biotech Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.3.5 DenovAI Biotech Recent Development
11.4 immunitoAI Private Limited
11.4.1 immunitoAI Private Limited Company Details
11.4.2 immunitoAI Private Limited Business Overview
11.4.3 immunitoAI Private Limited AI-based Antibody Development Platform Introduction
11.4.4 immunitoAI Private Limited Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.4.5 immunitoAI Private Limited Recent Development
11.5 EVQLV
11.5.1 EVQLV Company Details
11.5.2 EVQLV Business Overview
11.5.3 EVQLV AI-based Antibody Development Platform Introduction
11.5.4 EVQLV Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.5.5 EVQLV Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs AI-based Antibody Development Platform Introduction
11.6.4 Creative Biolabs Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.6.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Kyinno Biotechnolog
XtalPi Inc
DenovAI Biotech
immunitoAI Private Limited
EVQLV
Creative Biolabs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂